Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

Semaglutide, which is traditionally a treatment for type 2 diabetes, was given to participants who had been diagnosed with a life-threatening form of liver disease called metabolic dysfunction ...

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat accumulates in the liver, causing inflammation and scarring. Over time, this damage ...

Currently, there is only one FDA-approved treatment available ... “By treating both liver disease and its metabolic causes, semaglutide offers a promising new approach for millions of patients.” ...

Researchers excluded participants who had other chronic liver problems besides nonalcoholic fatty liver disease ... treatment modalities. The study in the NEJM showing possible benefits of ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

A game-changing medication known for diabetes and weight loss might also hold the key to improving liver health for millions of Americans.

Semaglutide, which is traditionally a treatment for type 2 diabetes, was given to participants who had been diagnosed with a life-threatening form of liver disease called metabolic dysfunction ...